Science publications

See a selection of publications, spotlighting our efforts to treat unmet medical need

08 February 2024

Gepotidacin, a new first-in-class antibiotic for treating uncomplicated urinary tract infection

Escherichia Coli (E. Coli) Bacteria Science Image

08 February 2024

Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials

GSK authors: Caroline R Perry, PHD; Nicole E Scangarella-Oman, MSc; Helen Millns, PHD; Marcy Powell, MD

Escherichia Coli (E. Coli) Bacteria Science Image

27 July 2023

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study

GSK authors: Barbara J Klencke, MD; Jing Yu, PhD; Rafe Donahue, PhD; Jun Kawashima, MD

Anaemia Blood Cells Image

08 June 2023

Dostarlimab for primary advanced or recurrent endometrial cancer

GSK authors: Min Tian, PhD; Zangdong He, PhD; Shadi Stevens, MD; Eleftherios Zografos, MD; Matthew A. Powell, MD​

Endometrial Cancer Science Image

16 February 2023

Respiratory syncytial virus prefusion F protein vaccine in older adults

GSK authors: Nancy Dezutter, PhD; Nathalie de Schrevel, PhD; Laurence Fissette, MS; Marie-Pierre David, MS; Marie Van der Wielen, MD; Lusine Kostanyan, MD; Veronica Hulstrøm, MD, PhD

Respiratory Syncytial Virus (RSV) Science Image

28 January 2023

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

GSK authors: Barbara J Klencke, MD; Sunhee Ro, PhD; Rafe Donahue, PhD; Jun Kawashima, MD

Anaemia Blood Cells Image

24 November 2022

Efficacy and safety of bepirovirsen in chronic hepatitis B infection

GSK authors: Jennifer Cremer, PharmD; Robert Elston, PhD; Tamara Lukić, MD; Geoff Quinn, MSc; Lauren Maynard, MSc; Stuart Kendrick, PhD; Helene Plein, PhD; Melanie Paff, PhD; and Dickens Theodore, MD, MPH

GSK Hepatitis B science image

29 July 2022

Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years

GSK authors: Frank Malinoski; Shite Sebastian; George Siber; Richard Malley

Lungs Science Image